Romark snares FDA nod to make diarrhea med Alinia at Puerto Rico plant—and supply a COVID candidate's trials, too

Romark's manufacturing facility in Manati, Puerto Rico, snagged clearance from the FDA to produce the diarrhea med Alinia for the U.S. market, the company said in a release. The green light covers production of 500-milligram tablets and 100-milligram/5-milliliter oral suspension formulations of Alinia, known by the generic name nitazoxanide.